A less invasive test for Alzheimer’s is a big advance. But it’s not perfect and is not meant to screen healthy people.

A new classification tree offers a practical alternative for evaluating esophagogastric junction outflow disorders when more ...

Diagnostics company Nutromics has presented the world's first real-time, continuous data on two critical antibiotics - vancomycin and tobramycin - measured simultaneously on the same device in animal ...

The discoveries and progress in medicine, biology, and chemistry in the last decades have revolutionized diagnostic and ...

People with rheumatoid arthritis (RA) who experienced disease flares often showed changes in heart rate and physical activity ...

Implantable biosensors and wearable technologies have the potential to enable continuous, real-time monitoring of kidney and ...

Scream, Scooby Doo and soon to be Scream 7 star Matthew Lillard is now involved in a "Screen" campaign to raise awareness ...

A remarkably low translation rate of 0.14% of colorectal cancer (CRC) biomarkers have been approved for patient care. The ...

Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, specializes in blood-based cancer diagnostics, with ...

HealthDay News — No controlled studies report benefits of screening with multicancer detection (MCD) tests, according to a study published online Sept. 16 in the Annals of Internal Medicine.

Glypican-3 (GPC3) has emerged as a promising immunotherapeutic target for hepatocellular carcinoma (HCC). However, its ...

A monocyte mitochondrial superoxide cutoff accurately stratified short-term survival risk in hepatocellular carcinoma.